Login / Signup

Incidence of Systemic Vasculitis and Clinical Outcomes in Systemic Sclerosis: 2-Years Follow-Up of Asymptomatic Positive for Anti-Neutrophilic Cytoplasmic Antibody.

Raiwin SuwannamajoAjanee MahakkanukrauhSiraphop SuwannarojChingching Foocharoen
Published in: Clinical, cosmetic and investigational dermatology (2024)
AAV is a rare complication in SSc, so ANCA may not have any role as a screening test for AAV as it cannot predict the development of AAV in SSc. We suggest testing for ANCA only in SSc patients with clinicals suspicious of AAV.
Keyphrases
  • systemic sclerosis
  • gene therapy
  • interstitial lung disease
  • risk factors